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Abstract 
Background: Biologically produced alkanes can be used as ‘drop in’ to existing transportation infrastructure as 
alkanes are important components of gasoline and jet fuels. Despite the reported microbial production of alkanes, the 
toxicity of alkanes to microbial hosts could pose a bottleneck for high productivity. In this study, we aimed to improve 
the tolerance of Saccharomyces cerevisiae, a model eukaryotic host of industrial significance, to alkane biofuels.
Results: To increase alkane tolerance in S. cerevisiae, we sought to exploit the pleiotropic drug resistance (Pdr) tran-
scription factors Pdr1p and Pdr3p, which are master regulators of genes with pleiotropic drug resistance elements 
(PDREs)-containing upstream sequences. Wild-type and site-mutated Pdr1p and Pdr3p were expressed in S. cerevisiae 
BY4741 pdr1Δ pdr3Δ (BYL13). The point mutations of PDR1 (F815S) and PDR3 (Y276H) in BYL13 resulted in the highest 
tolerance to C10 alkane, and the expression of wild-type PDR3 in BYL13 led to the highest tolerance to C11 alkane. 
To identify and verify the correlation between the Pdr transcription factors and tolerance improvement, we analyzed 
the expression patterns of genes regulated by the Pdr transcription factors in the most tolerant strains against C10 
and C11 alkanes. Quantitative PCR results showed that the Pdr transcription factors differentially regulated genes 
associated with multi-drug resistance, stress responses, and membrane modifications, suggesting different extents 
of intracellular alkane levels, reactive oxygen species (ROS) production and membrane integrity. We further showed 
that (i) the expression of Pdr1mt1 + Pdr3mt reduced intracellular C10 alkane by 67 % and ROS by 53 %, and significantly 
alleviated membrane damage; and (ii) the expression of the Pdr3wt reduced intracellular C11 alkane by 72 % and ROS 
by 21 %. Alkane transport assays also revealed that the reduction of alkane accumulation was due to higher export 
(C10 and C11 alkanes) and lower import (C11 alkane).
Conclusions: We improved yeast’s tolerance to alkane biofuels by modulating the expression of the wild-type and 
site-mutated Pdr1p and Pdr3p, and extensively identified the correlation between Pdr transcription factors and toler-
ance improvement by analyzing gene patterns, alkane transport, ROS, and membrane integrity. These findings pro-
vide valuable insights into manipulating transcription factors in yeast for improved alkane tolerance and productivity.
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Background
Biologically synthesized alkanes can be used as ‘drop 
in’ to existing transportation infrastructure as alkanes 
are important components of gasoline and jet fuels [1]. 
Even though alkanes have been successfully produced in 
microbes [2–8], the yields and titers should be a key con-
sideration for industrial-scale production, and the tox-
icity of alkanes to microbial hosts could eventually be a 
bottleneck for high productivity [9, 10].
Our previous transcriptome analyses suggested that 
alkanes induce a range of cellular mechanisms such as 
efflux pumps, membrane modification, radical detoxi-
fication, and energy supply in yeast [9]. Indeed, the 
mechanisms underlying cell responses to toxic molecules 
can provide useful strategies to improve cell tolerance 
and viability. Such strategies include engineering efflux 
pumps [9–12] and transcription factors [13–17], and 
modifying cellular membrane [18]. Transcription factors 
regulate multiple and simultaneous perturbations of the 
transcriptome towards a global phenotype of tolerance 
[19]. By knockout or overexpression of transcription fac-
tors involved in genetic regulatory networks of isooctane 
response in Escherichia coli, Kang et  al. [20] improved 
E. coli’s tolerance to isooctane. In addition, Matsui et al. 
discovered a modified transcription factor endowing 
Saccharomyces cerevisiae with organic-solvent tolerance 
[21].
Towards the development of alkane-tolerant S. cerevi-
siae, a well-studied model eukaryote with wide industrial 
applications, we sought to exploit its transcription factors 
Pdr1p and Pdr3p, which are master regulators of genes 
with pleiotropic drug resistance elements (PDREs)-con-
taining upstream sequences [22]. Currently, a thorough 
investigation of the roles of Pdr1p and Pdr3p in cellular 
tolerance to alkanes is lacking. In this study, we demon-
strated a significant improvement in yeast’s tolerance to 
n-decane (C10) and n-undecane (C11) by modulating 
the expression of wild-type and site-mutated Pdr1p and 
Pdr3p. The correlation between Pdr transcription factors 
and tolerance improvement was confirmed by analyzing 
gene patterns, alkane transport, reactive oxygen species 
(ROS) levels, and membrane integrity.
Results and discussion
Site‑mutation of PDR1 and PDR3
Transcription factor engineering is widely used to 
improve microbial strain tolerance against toxic mol-
ecules [12, 14]. In S. cerevisiae, transcription factors 
Pdr1p and Pdr3p have a DNA-binding domain, an inhibi-
tory domain, and a transcription activation domain. The 
inhibitory domain in a locked conformation interacts 
with the transcription activation domain [23, 24], which 
is associated with Pdr-DNA or Pdr–Pdr interactions and 
pleiotropic drug resistance. Amino acid substitutions 
in the inhibitory domains could alter the actions of the 
transcription activation domain, leading to changes in 
Pdr1 and Pdr3 activity and the pleiotropic drug resist-
ance. Recently, a series of site mutations in the inhibi-
tory domains have been shown to improve pleiotropic 
drug resistance, and three site mutations (F815S and 
R821S in Pdr1p, and Y276H in Pdr3p) are most effective 
to improve the tolerance against various toxic molecules 
[21, 23–25]. Currently, a thorough investigation of the 
roles of these mutations in cellular tolerance to alkanes 
is lacking. In this study, we chose F815S and R821S in 
Pdr1p and Y276H in Pdr3p for improving the tolerance 
to alkane biofuels in S. cerevisiae. Figure 1 shows the cho-
sen mutation sites and cloning of the wild-type and site-
mutated PDR1 and PDR3 into pESC-Ura. We induced 
the expression of the wild-type and site-mutated PDR1 
and PDR3 in a double gene-deletion mutant S. cerevisiae 
BYL13 (pdr1Δ pdr3Δ).
Conditions for protein induction and alkane exposure
To test yeast cell tolerance towards alkanes, we deter-
mined suitable conditions for protein induction and 
alkane exposure. Additional file 1: Figure S1A shows that 
the growth of BYL13 expressing the site-mutated Pdr 
transcription factor genes was inhibited, suggesting that 
lower induction of the Pdr transcription factors might 
lead to lower growth inhibition. To determine suitable 
induction conditions, we added various amounts of galac-
tose (0.5 g/l, 5 g/l, and 20 g/l) and compared the result-
ing cell densities. Additional file 1: Figure S1B shows that 
the growth inhibition was lower (one-tailed Student t 
test, p < 0.05) at 24 h when the expression was induced 
by a lower concentration of galactose (0.5 g/l). Hence, we 
chose to use 0.5 g/l of galactose for the induction of tran-
scription factor expression in further experiments.
Medium chain alkanes (C8–C12) are important com-
ponents of transportation fuels such as gasoline and jet 
fuels. As C12 alkane exhibits insignificant toxicity to 
S. cerevisiae [10], we aimed to improve yeast tolerance 
towards C8, C9, C10, and C11 alkanes. Additional file 1: 
Figure S2 shows that 5 % of C8, C9, or C11 alkanes, and 
1 % of C10 alkane inhibited the growth of BYL13 carrying 
empty pESC-Ura plasmid. These alkane concentrations, 
together with 0.5  g/l of galactose, were used for deter-
mining engineered yeast tolerance towards alkanes.
Tolerance of BYL13 expressing Pdr transcription factors 
towards alkanes
We then investigated the tolerance of BYL13 express-
ing Pdr transcription factors against C8, C9, C10, and 
C11 alkanes. Figure  2a and Additional file  1: Figure S3 
show that in the presence of (i) 1 % C10 alkane, BYL13 
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expressing the site-mutated Pdr transcription factors 
(particularly Pdr1mt1  +  Pdr3mt) had significantly higher 
cell densities than the control cells (with pESC-Ura); 
and (ii) 5 % C11 alkane, BYL13 expressing the wild-type 
Pdr transcription factors (particularly Pdr3wt) had sig-
nificantly higher cell densities, whilst BYL13 expressing 
the site-mutated Pdr transcription factors had modestly 
higher cell densities than the controls. The enhanced 
cell densities correspond with increased cell viability 
(Fig.  2b). However, there was no improvement in toler-
ance in BYL13 expressing the wild-type Pdr transcrip-
tion factors against C10 alkane, or in BYL13 expressing 
any Pdr transcription factors against C8 or C9 alkanes. 
Expression of the representative transcription fac-
tors (Pdr1mt1  +  Pdr3mt, and Pdr3wt) was confirmed by 
Western blots (Additional file 1: Figure S4). Furthermore, 
we performed quantitative PCR (qPCR) to understand 
the roles of PDR expression levels and site mutations in 
the tolerance improvement. Additional file  2: Tables S1 
and S2 show that the C10 tolerance was attributed to the 
site mutations (Pdr1 F815S, and Pdr3 Y276H) regardless 
of the PDR1mt1 and PDR3mt expression levels. The results 
of the growth assays and expression analyses indicate 
that the expression of Pdr transcription factors improved 
yeast tolerance to C10 and C11 alkanes.
Gene patterns in BYL13 expressing Pdr1mt1 + Pdr3mt 
and Pdr3wt in the presence of C10 and C11 alkanes
The improved alkane tolerance of yeast, conferred by 
the expression of Pdr1mt1 +  Pdr3mt or Pdr3wt, might be 
Fig. 1 Site mutagenesis of PDR1 and PDR3, and plasmid construction. Plasmid pESC-Ura (http://www.chem-agilent.com) was used as a vector to 
express the transcription factors. Wild-type and mutant alleles of PDR1 and PDR3 were cloned into MCS2 and MCS1, respectively. Asterisks mutation 
sites
a b
Fig. 2 Tolerance of BYL13 + Pdr (Pdr1mt1 + Pdr3mt and Pdr3wt) against C10 and C11 alkanes. a Cell density (OD600) of BYL13 expressing 
Pdr1mt1 + Pdr3mt against 1 % C10 (PDR1mt1 + PDR3mt + C10), and BYL13 expressing Pdr3wt against 5 % C11 (PDR3wt + C11) was measured every 
12 h. Error bars SD from three biological replicates. b Ten microliters of serially diluted cells (24 h) were spotted onto YPD agar plates for cell viability 
assays. Control, BYL13 with pESC-Ura
Page 4 of 11Ling et al. Biotechnol Biofuels  (2015) 8:231 
contributed to by perturbations made to the expression 
levels of the genes regulated by the Pdr transcription fac-
tors, such as ABC efflux pump genes, stress responsive 
genes, and genes involved in membrane modifications 
[22]. To examine this possibility, we studied the expres-
sion patterns of those target genes in the presence of C10 
and C11 alkanes by qPCR.
First, to choose a suitable reference gene, we evaluated 
expression stability of five reference genes (ACT1, ALG9, 
TAF10, UBC6, and TFC1) by comparing their M values 
under the above conditions. Here, a lower M value stands 
for higher stability of gene expression [26, 27]. Additional 
file  2: Table S1 shows that UBC6 gene had the lowest 
M value out of the five reference gene candidates under 
the conditions of Pdr expression and alkane exposure. 
Hence, UBC6 was chosen as the reference gene for qPCR 
analyses.
Second, we compared expression levels of the target 
genes in BYL13 expressing Pdr1mt1 + Pdr3mt (in the pres-
ence of C10 alkane) or Pdr3wt (in the presence of C11 
alkane) to those in BYL13 under exposure to C10 or C11 
alkane. Figure  3 shows that, in BYL13 expressing either 
Pdr1mt1 +  Pdr3mt (C10) or Pdr3wt (C11), (i) ABC efflux 
pump genes (i.e., YOR1, SNQ2, PDR5, and PDR15) were 
up-regulated by 4.2 to 46.6-fold (C10) and 1.6 to 17.1-fold 
(C11); (ii) cytosolic catalase gene CTT1 was up-regulated 
by 2.1-fold (C10) and 2.6-fold (C11); and (iii) lysophos-
phatidic acid acyltransferase gene ICT1 was up-regu-
lated by 5.8-fold (C10) and 3.4-fold (C11). Considering 
the roles of the efflux pump genes in multi-drug resist-
ance (MDR) [28], CTT1 in ROS detoxification [29], and 
ICT1 in membrane modifications [18], we hypothesized 
that intracellular alkane amount, ROS levels, the effi-
ciency of alkane transport, and membrane damage might 
be involved in the increased alkane tolerance of BYL13 
expressing Pdr1mt1  +  Pdr3mt or Pdr3wt. This hypothesis 
was investigated, as explained in the following sections.
Alkane levels in BYL13 expressing Pdr1mt1 + Pdr3mt 
and Pdr3wt
To investigate the effect of the expression of 
Pdr1mt1  +  Pdr3mt or Pdr3wt on intracellular alkane lev-
els, we quantified intracellular C10 and C11 alkanes by 
gas chromatography (GC) analyses. Figure 4a shows that 
(i) upon exposure to C10 alkane, the intracellular C10 
alkane amount was reduced by 67 % in BYL13 expressing 
Pdr1mt1 + Pdr3mt; and (ii) upon exposure to C11 alkane, 
the intracellular C11 alkane amount was reduced by 72 % 
in BYL13 expressing Pdr3wt.
Given that C10 and C11 alkanes are not metabolized by 
S. cerevisiae, we hypothesized that the lower intracellular 
levels of alkanes in BYL13 expressing Pdr transcription 
factors could be due to alkanes efflux, reduced import, 
or both. First, to investigate the involvement of alkane 
efflux in reducing alkane accumulation, we exposed 
BYL13 expressing Pdr1mt1  +  Pdr3mt to C10 alkane and 
BYL13 expressing Pdr3wt to C11 alkane. Following this, 
the ABC efflux pumps were deactivated, and the intracel-
lular alkane amount with and without active ABC efflux 
pumps was compared. Here, NaN3 functions as a meta-
bolic inhibitor that interferes with ABC transporters. 
The ABC transporters in the cells without NaN3 treat-
ment are still active in alkane efflux. Under the condi-
tion of no NaN3 treatment, reduction of the intracellular 
alkane amounts is attributed to alkane efflux associated 
with the ABC efflux pumps, vise versa. Figure 4b shows 
that in comparison to the alkane levels in BYL13, C10 
and C11 alkane levels in BYL13 with active ABC efflux 
pumps were reduced by 19.9 and 34.5  %, respectively. 
This result suggests significant reduction in intracellu-
lar C10 and C11 alkanes was contributed by ABC efflux 
pumps-associated alkanes export. Second, to verify 
whether lower import of alkanes contributed to reducing 
intracellular alkane levels, we added NaN3 to deactivate 
ABC efflux pumps, and then exposed the cells to C10 
and C11 alkanes, and quantified intracellular alkanes. 
Upon the deactivation of the ABC transporters by NaN3, 
there is no ABC efflux pumps-associated alkane efflux 
during alkane import. Under this condition, lower intra-
cellular alkane amounts are attributed to lower alkane 
import, vise versa. Figure  4c shows that, in comparison 
to the control without Pdr transcription factors, (i) C10 
alkane amount was comparable in BYL13 expressing 
Pdr1mt1 + Pdr3mt, suggesting no difference in C10 alkane 
import despite the up-regulation of ICT1 in BYL13 
Fig. 3 Relative gene expression levels under the regulation 
of Pdr transcription factors in the presence of C10 and C11 
alkanes. In the induction medium containing 0.5 g/l galactose, 
BYL13 + Pdr1mt1 + Pdr3mt cells were exposed to 1 % C10 alkane 
(PDR1mt1 + PDR3mt + C10), and BYL13 + Pdr3wt cells were exposed 
to 5 % C11 alkane (PDR3wt + C11). The expression levels of genes at 
24 h were normalized to those in controls (BYL13 + pESC-Ura + C10, 
BYL13 + pESC-Ura + C11) and the reference gene UBC6. Error bars SD 
from three biological replicates
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expressing Pdr1mt1 + Pdr3mt; and (ii) C11 alkane amount 
in BYL13 expressing Pdr3wt was reduced by 42.2 %, sug-
gesting lower import of C11, which is consistent with the 
up-regulation of ICT1. Hence, these results suggest that 
alkane efflux might contribute to C10 reduction, and 
both alkane efflux and low import to C11 reduction.
ROS levels in BYL13 expressing Pdr1mt1 + Pdr3mt 
and Pdr3wt with C10 and C11 alkanes
ROS levels were quantified to investigate the effect of 
Pdr transcription factor expression on ROS produc-
tion in the presence of alkanes. Figure  5a, b shows that 
C10 alkane enhanced ROS levels by more than fourfold 
whereas C11 alkane increased ROS levels by 1.5-fold. 
Further, in comparison to BYL13 carrying pESC-Ura, 
intracellular ROS was reduced by 53 % in BYL13 express-
ing Pdr1mt1  +  Pdr3mt in the presence of C10 alkane, 
and reduced by 21 % in BYL13 expressing Pdr3wt in the 
presence of C11 alkane. The reduction of ROS in BYL13 
expressing the Pdr transcription factors was further sup-
ported by our microscopy results. Figure 5c shows that, 
upon exposure to C10 alkane, over 90 % of the cells with 
pESC-Ura fluoresced in green, and only about 30  % of 
the cells with Pdr1mt1 + Pdr3mt fluoresced in green. On 
the other hand, upon exposure to C11 alkane, 15  % of 
the cells with pESC-Ura fluoresced in green, and no cells 
with Pdr3wt fluoresced in green. Here, more green cells 
and higher fluorescence intensities represent more ROS. 
The results of ROS quantification and microscopy sug-
gest significant reduction of ROS in BYL13 expressing 
the Pdr transcription factors in the presence of C10 and 
C11 alkanes.
Membrane integrity of BYL13 expressing Pdr1mt1 + Pdr3mt 
and Pdr3wt in the presence of C10 and C11 alkanes
The qPCR results in Fig.  3 show that ICT1, associated 
with membrane modifications, was up-regulated in 
BYL13 expressing Pdr transcription factors upon expo-
sure to C10 and C11 alkanes, suggesting that membrane 
integrity might be affected upon exposure to alkanes 
[30]. Here, we aimed to study the membrane integrity of 
BYL13 expressing Pdr transcription factors in the pres-
ence of alkanes.
To this end, we exposed the cells to C10 and C11 
alkanes and stained the exposed cells with fluorescence 
nucleic acid stains PI and SYTO 9. Subsequently, we 
measured fluorescence signals and observed the cells 
under microscope. Figure 6a shows that relative fluores-
cence unit (RFU) ratios of PI to SYTO 9 were enhanced 
by 16.7-fold in BYL13 with pESC-Ura, and enhanced by 
6.4-fold in BYL13 expressing Pdr1mt1  +  Pdr3mt, upon 
exposure to C10 alkane as compared with those without 
alkane exposure. Moreover, in the presence of C10 alkane, 
the RFU ratio in BYL13 expressing Pdr1mt1 + Pdr3mt was 
about 62 % lower than that with pESC-Ura, likely due to 




Fig. 4 Analyses of intracellular alkane levels in BYL13 expressing 
Pdr transcription factors. a Upon exposure to C10 and C11 alkanes, 
respectively, intracellular alkanes were extracted, measured by GC, 
and quantified by normalizing areas of GC peaks to those of an 
internal standard (IS) n-dodecane as well as corresponding protein 
amount. b To identify involvement of ABC efflux pumps in reducing 
intracellular alkanes, intracellular alkanes were compared between 
BYL13 expressing Pdr transcription factors with and without NaN3. c 
To verify lower import of alkanes, intracellular alkanes were compared 
between BYL13 with pESC-Ura and expressing Pdr transcription 
factors in the presence of NaN3. Alkane amount in cells with pESC-
Ura, and with NaN3 were set as 1. Asterisks significant difference 
(one-tailed Student t test, p < 0.05); error bars SD from three biological 
replicates
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of C10 alkane. However, Fig. 6b shows that, in the pres-
ence of C11 alkane, both BYL13 with Pdr3wt and the con-
trol cells had comparable RFU ratios, suggesting intact 
cell membrane in the presence of C11 alkane.
The low RFU ratio suggests that BYL13 expressing 
Pdr1mt  +  Pdr3mt had less membrane damage than the 
control cells in the presence of C10 alkane, and the com-
parable ratios suggest no membrane damage to both 
BYL13 expressing Pdr3wt and the control cells in the pres-
ence of C11 alkane, in line with the fluorescence micros-
copy images in Fig. 6c.
In this study, we improved yeast’s alkane tolerance by 
expressing wild-type or site-mutated Pdr transcription 
factors in S. cerevisiae pdr1Δ pdr3Δ, and provided the 
evidence that, in the most tolerant strains expressing 
Pdr transcription factors, (i) a series of genes (e.g., ABC 
efflux pump genes, CTT1, and ICT1) were up-regulated 
by C10 and C11 alkanes; (ii) intracellular alkane lev-
els were reduced over 67  % due to alkane efflux and/or 
low import; and (iii) ROS levels were reduced over 21 %; 
and (iv) cell membrane damage was also reduced. How-
ever, expression of any Pdr transcription factors did not 
improve tolerance to C8 or C9 alkanes at toxic levels. 
The susceptibility of yeast to alkanes is associated with 
multiple factors such as alkane carbon-chain length, 
alkane concentration, and strain background. Additional 
file  1: Figure S2 shows that, more C8 and C9 alkanes 
were required to inhibit BYL13 with pESC-Ura than 
C10 alkane, although C8 and C9 alkanes are more toxic 




Fig. 5 Quantification of ROS levels in BYL13 expressing Pdr transcription factors. a and b ROS levels upon exposure to C10 and C11 alkanes. The 
relative ROS levels of BYL13 without alkane were set to 1. c Comparison of fluorescence images, where stronger green fluorescence indicates higher 
ROS levels. AU arbitrary unit. Asterisk significant difference (one-tailed Student t test, p < 0.05); error bars SD from three biological replicates
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C9 alkanes are more volatile than longer-chain alkanes. 
Furthermore, although Pdr1p and Pdr3p improved tol-
erance to C10 and C11 alkanes in BYL13, we found that 
Pdr1 R821S (Pdr1mt2) could not improve tolerance to C9 
alkane, which is inconsistent with a previous study [21]. 
This discrepancy is likely due to difference of strain back-
ground between BYL13 and KK-211 used in the previ-
ous study. To demonstrate that strain background can 
affect cell tolerance towards alkanes, we expressed either 
Pdr1mt1 + Pdr3mt or Pdr3wt in BY4741, a parental strain 
of BYL13, and evaluated the cell growth in the presence 
of alkanes. Figure 2 and Additional file 1: Figure S5 show 
that BY4741 expressing Pdr transcription factors grew 
better than BYL13 expressing the same Pdr transcription 
factors upon exposure to C10 and C11 alkanes.
According to Mamnun and coworkers [22], Pdr1p and 
Pdr3p form homo- and hetero-dimers to mediate pleio-
tropic drug resistance in S. cerevisiae, and these homo- 
and hetero-dimers could show diverse transcriptional 
activity to their target genes involved in tolerance to 
alkanes. In line with the diversity of Pdr dimers and their 
transcriptional activity, Fig. 2 and Additional file 1: Figure 
S3 indicate discrepant tolerance conferred by the individ-
ual and co-expressed Pdr transcription factors.
Future efforts could be made to identify DNA-binding 
efficacy of Pdr1p- and Pdr3p-dimers as well as influences 
of various Pdr dimers on the transcriptome in response 
to alkanes, and to discriminate significance of each mech-
anism (alkanes efflux, membrane modifications, ROS 
reduction, and alleviation of membrane damage) in the 
Pdr transcription factors involving tolerance improve-
ment towards alkane biofuels. In addition, a tool of global 
transcription machinery engineering (gTME) [19] can be 
applied to construct Pdr transcription factor libraries and 
obtain phenotypes of resistance against a wide spectrum 
of biochemical molecules.
Conclusions
The site mutants Pdr1 F815S  +  Pdr3 Y276H 




Fig. 6 Assays of membrane integrity in BYL13 expressing Pdr transcription factors. a and b RFU ratios of PI and SYTO 9 upon exposure to C10 and 
C11 alkanes. The relative RFU ratios of BYL13 without alkane were set to 1. c Representative fluorescent images. Error bars SD from three biological 
replicates
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improved the tolerance of BYL13 and BY4741 to C10 and 
C11 alkanes, respectively. We found that the mechanisms 
underlying Pdr1p- and Pdr3p-mediated tolerance are 
multilayered. As depicted in Fig. 7, we hypothesize that 
Pdr1p and Pdr3p regulate genes involved in alkane efflux 
(e.g., SNQ2, and PDR5), stress responses (e.g., CTT1) 
and membrane modifications (e.g., ICT1) in the presence 
of C10 and C11 alkanes. The tolerance to alkanes was 
improved through (i) reduced intracellular alkanes con-
tributed by alkane efflux (C10 and C11) and lower alkane 
import (C11 alkane), (ii) decreased ROS production 
probably contributed by lower alkane accumulation (C10 
and C11 alkanes) and Ctt1p-mediated ROS decomposi-
tion (C10 and C11 alkanes), and (iii) alleviated membrane 
damage contributed to by membrane modifications (C10 
alkane). These findings provide valuable insights into 
engineering alkane-tolerant yeast for improved alkane 
productivity.
Methods
Strains, plasmids and growth conditions
Strains and plasmids used in this study are listed in 
Table  1. Yeast cells were grown at 30  °C in YPD (10  g/l 
Yeast Extract, 20 g/l Peptone, and 20 g/l Dextrose), mini-
mal medium (6.7 g/l Yeast Nitrogen Base, 20 g/l Dextrose, 
and 1.92  g/l Yeast synthetic dropout medium supple-
ments without uracil), or induction medium (6.7 g/l Yeast 
Nitrogen Base, 10 g/l D-raffinose, 1.92 g/l Yeast synthetic 
dropout medium supplements without uracil, and appro-
priate amount of D-(+)-galactose). E. coli was grown at 
37 °C in Luria–Bertani (LB) broth. Antibiotics (200 μg/ml 
G418, or 100 μg/ml Ampicillin) and appropriate amount 
of n-alkanes were added if necessary.
Disruption of PDR1 and PDR3
Gene disruption was carried out as previously described 
[31] using primers listed in Additional file  2: Table S3. 
First, gene disruption cassettes of loxP-Kan-loxP were 
amplified from pUG6 and transformed into S. cerevisiae 
BY4741. Colonies were screened on YPD agar plates con-
taining 200 μg/ml G418. Subsequently, pSH47 was trans-
formed into a single mutant BYL1K, and transformants 
were screened on minimal medium (Ura−) plates, fol-
lowed by Cre/loxP-mediated marker removal in galac-
tose-induction medium. Selection for loss of the marker 
was performed in YPD containing 1 mg/ml 5-fluoro-oro-
tic acid (Thermo Scientific). Finally, marker-free pdr1Δ 
(BYL1) was used as a parental strain for disruption of 
PDR3.
Gene cloning and expression
With S. cerevisiae BY4741 genomic DNA as a template, 
wild-type PDR1 and PDR3 were amplified using iProof 
High-Fidelity DNA Polymerase (Biorad) and gene-
specific primers (Additional file  2: Table S3). A-tailing 
of PCR products was performed with Taq polymerase 
(New England Biolabs). The PCR products were puri-
fied, cloned into pGEM-T (Promega) and confirmed by 
sequencing. Subsequently, correct recombinant plasmids 
were used as templates for site mutagenesis using Quick 
Change Site-Directed Mutagenesis Kit (Stratagene) 
according to a provided manual. Further, site mutations 
Fig. 7 A schematic of proposed mechanisms on tolerance improvement towards C10 (shaded in light blue) and C11 (shaded in light orange) alkanes 
conferred by Pdr1p and Pdr3p. Pdr1p and Pdr3p improve tolerance to C10 alkane likely through reducing membrane damage (A, blue), alkane efflux 
(B, green), and reducing ROS production (C, orange); the tolerance to C11 alkane is improved likely through reducing C11 import due to potential 
membrane modifications (D, purple), as well as (B) and (C)
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were confirmed by sequencing. Thereafter, wild-type and 
site mutants of PDR1 and PDR3 were amplified and co-
transformed with linearized pESC-Ura fragments into 
BYL13 by an in vivo DNA assembly method [32]. Finally, 
transformants were screened on minimal medium agar 
plates (Ura−) and characterized by PCR and sequenc-
ing. Here, PDR1 and its site mutants were cloned into 
multiple cloning site 2 (MCS2) under control of a galac-
tose-inducible promoter PGAL1, while PDR3 and its site 
mutant were cloned into MCS1 under control of another 
galactose-inducible promoter PGAL10. These PDR genes 
in MCS1 and MCS2 were individually expressed or co-
expressed under induction by galactose (Fig. 1).
Western blotting
Pdr proteins were induced in the induction medium con-
taining 0.5  g/l galactose for 24  h. Fifty milliliters of cells 
were collected and resuspended in ice-cooled lysis buffer 
(50  mM Tris–HCl pH7.9, 0.6  M sorbitol) added with 
protease inhibitor and 0.3  g acid-washed glass beads 
(diameter 425–600 μm). Cells were disrupted using Fast-
Prep-24 at 6 m/s for 30  s ×  10 cycles (MP Biomedicals, 
USA). Samples were chilled on ice for 5 min during each 
interval. Cell lysate was centrifuged at 4  °C to separate 
soluble and insoluble proteins. The insoluble part was dis-
solved with 8 M urea. The obtained protein samples were 
separated by SDS-PAGE, transferred onto nitrocellulose 
membrane, and hybridized with anti-Myc (for Pdr1p) and 
anti-Flag (for Pdr3p) antibodies (Abcam). Protein bands 
with positive signal were detected using SuperSignal West 
Pico Chemiluminescent Substrate (Thermo Scientific).
Tolerance tests
First, we determined conditions of protein induction. 
In induction media with 20  g/l galactose, we measured 
growth curves of BYL13 expressing Pdr transcription 
factors, and a strain with minimal growth was selected 
to optimize galactose concentrations. Subsequently, the 
selected strain was grown in induction media with galac-
tose (0.5 g/l, 5 g/l, and 20 g/l). Every 12 h, 100 μl cell cul-
ture was sampled to measure cell densities (OD600) by a 
BioTek microplate reader, and galactose concentration 
which gave low growth inhibition was chosen for toler-
ance tests. Second, we determined conditions of alkanes 
exposure as follows. BYL13 with pESC-Ura was grown in 
induction media with galactose at the previously deter-
mined concentration, and exposed to alkanes (v/v, C8: 
2, 5, 10  %, C9: 1, 2, 5  %, C10: 0.5, 1, 5, and C11: 5, 10, 
20  %). Based on growth curves, minimum concentra-
tions of alkanes that inhibited BYL13 with pESC-Ura 
were selected for tolerance tests. Third, to test tolerance 
of cells with Pdr transcription factors against alkanes, we 
grew the cells in induction media under the determined 
conditions for protein induction and alkanes exposure. 
Strains showing the highest cell densities were selected 
for further analyses.
Total RNAs extraction and quantitative PCR analyses
BYL13 expressing Pdr1 F815S/Pdr3 Y276H 
(Pdr1mt1  +  Pdr3mt) and wild-type Pdr3p (Pdr3wt) were 
exposed to 1  % C10 and 5  % C11, respectively, for 6  h. 
Thereafter, the treated cells were collected, and cell wall 
was disrupted by Lyticase (Sigma). Total RNAs were 
Table 1 Strains, plasmids and PDR alleles used in this study
Strains, plasmids, and genes Description Sources
S. cerevisiae strains
 BY4741 MATa; his3∆1; leu2∆0; met15∆0; ura3∆0 ATCC201388
 BYL1K pdr1::kanMX derived from BY4741 This study
 BYL13K pdr3::kanMX derived from BYL1K This study
 BYL13 pdr1∆ pdr3∆, KanMX-free BYL13K This study
Plasmids
 pESC-Ura Expression vector, Ura+ Agilent
 pRS42K Expression vector, Kan+ Euroscarf
 pSH47 A plasmid for marker rescue, Ura+ Euroscarf
 pUG6 A plasmid with a KanMX gene cassette, Amp+ Euroscarf
PDR1 and PDR3 alleles
 PDR1wt Wild-type PDR1 This study
 PDR1mt1 A site mutant of PDR1 with amino acid substitution of F815S This study, [24]
 PDR1mt2 A site mutant of PDR1 with amino acid substitution of R821S This study, [21]
 PDR1mt1+2 A site mutant of PDR1 with amino acid substitution of both F815S and R821S This study
 PDR3wt Wild-type PDR3 This study
 PDR3mt A site mutant of PDR3 with amino acid substitution of Y276H This study, [23]
Page 10 of 11Ling et al. Biotechnol Biofuels  (2015) 8:231 
extracted using an RNeasy Mini Kit (Qiagen) accord-
ing to a provided manual. Single-stranded cDNAs were 
synthesized from 1 µg total RNA using a RevertAid First 
Strand cDNA Synthesis Kit (Thermal Scientific). With 
an equal amount of cDNAs, qPCR was performed using 
gene-specific primers (Additional file  2: Table S3) and 
Biorad SsoFast EvaGreen Supermix, and fluorescence 
signals were detected and analyzed by a Biorad iQ5 opti-
cal system. Expression stability of five reference gene 
candidates (ACT1, ALG9, TAF10, TFC1, and UBC6) was 
evaluated subjective to M value [26, 27]. Finally, gene 
expression data were normalized to a reference gene 
UBC6 and controls. Here, samples from BYL13 with 
pESC-Ura and alkanes exposure were used as controls.
Alkane extraction and quantification
Alkanes were extracted by a chloroform–methanol 
extraction method [33] with modifications. First, BYL13 
expressing Pdr1mt1  +  Pdr3mt and BYL13 expressing 
Pdr3wt were exposed to 1  % C10 and 5  % C11, respec-
tively. Thereafter, the alkane-treated cells were collected, 
washed with 50  mM Tris–Cl (pH 7.5), and resuspended 
in 0.5 ml chloroform–methanol mixture (v/v: 2/1). With 
0.01 % n-dodecane (C12) and 0.3 g glass beads per sam-
ple, cells were lysed by FastPrep-24, and lysate was sepa-
rated by centrifugation at a top speed for 10 min at 4 °C. 
Supernatant was collected, and alkanes were extracted 
by adding appropriate amount of chloroform and 50 mM 
Tris–Cl (pH7.5). Finally, chloroform phases contain-
ing alkanes were injected into a GC 7890A system and 
analyzed under conditions as follows: with a HP-5 col-
umn (Agilent Technologies), oven temperature started at 
80 °C, held for 1 min, ramped at 20 °C/min until 180 °C, 
and held for 2 min; FID detector temperature remained at 
275 °C. A mixture of n-alkanes (10 ppm each) was used as 
a standard. Finally, areas of GC peaks were normalized to 
an internal standard and corresponding protein amount.
To investigate involvement of alkane efflux in reduc-
ing intracellular alkane amount, BYL13 expressing 
Pdr1mt1  +  Pdr3mt and BYL13 expressing Pdr3wt were 
grown until log phases and exposed to 1 % C10 and 5 % 
C11, respectively, for 1 h. Cells were washed and divided 
into two equal aliquots. The first aliquot was treated 
with 1  mM NaN3 for 80  min, to deactivate activities of 
ABC transporters [34]. Here, NaN3 functions as a meta-
bolic inhibitor that interferes with ABC transporters by 
decreasing the amount of ATP generated by mitochon-
dria. The second aliquot was incubated without NaN3 for 
80 min. Finally, alkanes were extracted and quantified.
To investigate involvement of alkanes import in reduc-
ing intracellular alkane amount, BYL13 expressing Pdr 
transcription factors (i.e., Pdr1mt1 + Pdr3mt, and Pdr3wt) 
and BYL13 with pESC-Ura (control), respectively, were 
grown in an alkane-free induction medium until log 
phases and treated with 1 mM NaN3 for 20 min to deacti-
vate activities of ABC transporters [34]. An equal amount 
of the NaN3-treated cells were subsequently exposed to 
1 % C10 and 5 % C11, respectively, for 1 h. After expo-
sure, alkanes were extracted and quantified.
ROS quantification and membrane integrity analyses
BYL13 expressing Pdr1mt1 + Pdr3mt and BYL13 express-
ing Pdr3wt at log phases were exposed to 1 % C10 and 5 % 
C11, respectively, for 6  h. Thereafter, the alkane-treated 
cells were collected and stained by CellROX® Green Rea-
gent (Life Technologies) for ROS analyses, and by SYTO 
9 and propidium iodide (PI) (Life Technologies) for 
membrane integrity analyses. Further, fluorescence sig-
nals from CellROX® Green Reagent were measured by a 
TECAN Infinite 200 microplate reader at wavelength of 
485  nm (Excitation, Ex)/535  nm (Emission, Em), while 
fluorescence signals from PI and SYTO 9 were meas-
ured at wavelength of 535  nm (Ex)/590  nm (Em) and 
485  nm (Ex)/535  nm (Em), respectively. The acquired 
fluorescence signals were normalized to cell densities 
(OD600) if necessary. In addition, the stained cells were 
observed at wavelength of 535 nm (Ex)/590 nm (Em) and 
470 nm (Ex)/525 nm (Em) under a Zeiss Axio Scope.A1 
microscope.
Abbreviations
PDR: pleiotropic drug resistance; Wt: wild type; Mt: mutant; C8: n-octane; C9: 
n-undecane; C10: n-decane; C11: n-undecane; C12: n-dodecane; ROS: reactive 
oxygen species; ABC: ATP-binding cassette; MCS: multiple cloning sites; PI: 
propidium iodide; qPCR: quantitative PCR; RFU: relative fluorescence unit.
Authors’ contributions
HL and MWC conceived the project and designed the experiments. HL carried 
out gene disruption, ROS and membrane integrity analyses, and participated 
in alkane detection and tolerance tests. NKPJ carried out Western blotting and 
participated in tolerance tests. WST carried out gene cloning and participated 
in alkane detection. RL carried out RNA extraction and qPCR analyses. HL, SSJL 
and MWC wrote the manuscript. MWC supervised the project. All authors read 
and approved the final manuscript.
Author details
1 Department of Biochemistry, Yong Loo Lin School of Medicine, National 
University of Singapore, 8 Medical Drive, 117597 Singapore, Singapore. 
Additional files
 Additional file 1. Additional figures. Figure S1. Growth inhibition by 
expression of the site-mutants of Pdr transcription factors, and determina-
tion of suitable galactose concentrations. Figure S2. Determination of 
alkane exposure concentrations. Figure S3. Growth of BYL13 expressing 
Pdr transcription factors in the presence of alkanes. Figure S4. Western 
blotting of Pdr proteins in BYL13. Figure S5. Tolerance of BY4741 express-
ing Pdr transcription factors against C10 and C11 alkanes. 
Additional file 2. Additional tables.Table S1. M values of reference gene 
candidates derived from qPCR data. Table S2. Fold changes of PDR genes 
expressed in BYL13 stains as compared to BY4741. Table S3. Primers used 
in this study.
Page 11 of 11Ling et al. Biotechnol Biofuels  (2015) 8:231 
2 NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), 
Life Sciences Institute, National University of Singapore, 28 Medical Drive, 
117456 Singapore, Singapore. 3 Singapore Institute of Technology, 10 Dover 
Drive, 138683 Singapore, Singapore. 
Acknowledgements
This study was financially supported by the Competitive Research Program of 
the National Research Foundation of Singapore (NRF-CRP5-2009-03), and the 
Defense Threat Reduction Agency (DTRA, HDTRA1-13-1-0037).
Competing interests
The authors declare that they have no competing interests.
Received: 31 August 2015   Accepted: 4 December 2015
References
 1. Peralta-Yahya PP, Zhang F, del Cardayre SB, Keasling JD. Microbial engi-
neering for the production of advanced biofuels. Nature. 2012;488:320–8.
 2. Blazeck J, Liu L, Knight R, Alper HS. Heterologous production of pentane 
in the oleaginous yeast Yarrowia lipolytica. J Biotechnol. 2013;165:184–94.
 3. Yang X, Dai X, Guo H, Geng S, Wang G. Petrodiesel-like straight chain 
alkane and fatty alcohol production by the microalga Chlorella sorokini-
ana. Bioresour Technol. 2013;136:126–30.
 4. Andre C, Kim SW, Yu XH, Shanklin J. Fusing catalase to an alkane-
producing enzyme maintains enzymatic activity by converting the 
inhibitory byproduct H2O2 to the cosubstrate O2. Proc Natl Acad Sci USA. 
2013;110:3191–6.
 5. Schirmer A, Rude MA, Li X, Popova E, del Cardayre SB. Microbial biosyn-
thesis of alkanes. Science. 2010;329:559–62.
 6. Akhtar MK, Turner NJ, Jones PR. Carboxylic acid reductase is a versatile 
enzyme for the conversion of fatty acids into fuels and chemical com-
modities. Proc Natl Acad Sci USA. 2013;110:87–92.
 7. Bernard A, Domergue F, Pascal S, Jetter R, Renne C, Faure JD, Haslam RP, 
Napier JA, Lessire R, Joubes J. Reconstitution of plant alkane biosynthesis 
in yeast demonstrates that Arabidopsis ECERIFERUM1 and ECERIFERUM3 
are core components of a very-long-chain alkane synthesis complex. 
Plant Cell. 2012;24:3106–18.
 8. Choi YJ, Lee SY. Microbial production of short-chain alkanes. Nature. 
2013;502:571–4.
 9. Rasouliha BH, Ling H, Ho CL, Chang MW. A predicted immunity protein 
confers resistance to pyocin S5 in a sensitive strain of Pseudomonas 
aeruginosa. ChemBioChem. 2013;14:2444–6.
 10. Chen B, Ling H, Chang MW. Transporter engineering for improved toler-
ance against alkane biofuels in Saccharomyces cerevisiae. Biotechnol 
Biofuels. 2013;6:21.
 11. Dunlop MJ, Dossani ZY, Szmidt HL, Chu HC, Lee TS, Keasling JD, Hadi MZ, 
Mukhopadhyay A. Engineering microbial biofuel tolerance and export 
using efflux pumps. Mol Syst Biol. 2011;7:487.
 12. Lo TM, Teo WS, Ling H, Chen B, Kang A, Chang MW. Microbial engineering 
strategies to improve cell viability for biochemical production. Biotechnol 
Adv. 2013;31:903–14.
 13. Lin Y, Chomvong K, Acosta-Sampson L, Estrela R, Galazka JM, Kim SR, Jin 
Y-S, Cate JH. Leveraging transcription factors to speed cellobiose fermen-
tation by Saccharomyces cerevisiae. Biotechnol Biofuels. 2014;7:126.
 14. Ling H, Teo W, Chen B, Leong SS, Chang MW. Microbial tolerance engi-
neering toward biochemical production: from lignocellulose to products. 
Curr Opin Biotechnol. 2014;29C:99–106.
 15. Kang A, Tan MH, Ling H, Chang MW. Systems-level characterization and 
engineering of oxidative stress tolerance in Escherichia coli under anaero-
bic conditions. Mol BioSyst. 2013;9:285–95.
 16. Tamayo-Ramos J, Orejas M. Enhanced glycosyl hydrolase production in 
Aspergillus nidulans using transcription factor engineering approaches. 
Biotechnol Biofuels. 2014;7:103.
 17. Alper H, Moxley J, Nevoigt E, Fink GR, Stephanopoulos G. Engineering 
yeast transcription machinery for improved ethanol tolerance and pro-
duction. Science. 2006;314:1565–8.
 18. Ghosh AK, Ramakrishnan G, Rajasekharan R. YLR099C (ICT1) encodes 
a soluble Acyl-CoA-dependent lysophosphatidic acid acyltransferase 
responsible for enhanced phospholipid synthesis on organic solvent 
stress in Saccharomyces cerevisiae. J Biol Chem. 2008;283:9768–75.
 19. Alper H, Stephanopoulos G. Global transcription machinery engineer-
ing: a new approach for improving cellular phenotype. Metab Eng. 
2007;9:258–67.
 20. Kang A, Chang MW. Identification and reconstitution of genetic regula-
tory networks for improved microbial tolerance to isooctane. Mol BioSyst. 
2012;8:1350–8.
 21. Matsui K, Teranishi S, Kamon S, Kuroda K, Ueda M. Discovery of a modified 
transcription factor endowing yeasts with organic-solvent tolerance and 
reconstruction of an organic-solvent-tolerant Saccharomyces cerevisiae 
strain. Appl Environ Microbiol. 2008;74:4222–5.
 22. Mamnun YM, Pandjaitan R, Mahe Y, Delahodde A, Kuchler K. The 
yeast zinc finger regulators Pdr1p and Pdr3p control pleiotropic drug 
resistance (PDR) as homo- and heterodimers in vivo. Mol Microbiol. 
2002;46:1429–40.
 23. Nourani A, Papajova D, Delahodde A, Jacq C, Subik J. Clustered amino 
acid substitutions in the yeast transcription regulator Pdr3p increase 
pleiotropic drug resistance and identify a new central regulatory domain. 
Mol Gen Genet. 1997;256:397–405.
 24. Carvajal E, van den Hazel HB, Cybularz-Kolaczkowska A, Balzi E, Goffeau 
A. Molecular and phenotypic characterization of yeast PDR1 mutants 
that show hyperactive transcription of various ABC multidrug transporter 
genes. Mol Gen Genet. 1997;256:406–15.
 25. Mizoguchi H, Yamauchi T, Watanabe M, Yamanaka H, Nishimura A, 
Hanamoto H. Different missense mutations in PDR1 and PDR3 genes 
from clotrimazole-resistant sake yeast are responsible for pleiotropic 
drug resistance and improved fermentative activity. J Biosci Bioeng. 
2002;93:221–7.
 26. Teste MA, Duquenne M, Francois JM, Parrou JL. Validation of reference 
genes for quantitative expression analysis by real-time RT-PCR in Sac-
charomyces cerevisiae. BMC Mol Biol. 2009;10:99.
 27. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, Paepe A, 
Speleman F. Accurate normalization of real-time quantitative RT-PCR data 
by geometric averaging of multiple internal control genes. Genome Biol. 
2002;3:RESEARCH0034.
 28. Jungwirth H, Kuchler K. Yeast ABC transporters—a tale of sex, stress, 
drugs and aging. FEBS Lett. 2006;580:1131–8.
 29. Kim HS, Kim NR, Kim W, Choi W. Insertion of transposon in the vicinity of 
SSK2 confers enhanced tolerance to furfural in Saccharomyces cerevisiae. 
Appl Microbiol Biotechnol. 2012;95:531–40.
 30. Sikkema J, de Bont JA, Poolman B. Mechanisms of membrane toxicity of 
hydrocarbons. Microbiol Rev. 1995;59:201–22.
 31. Gueldener U, Heinisch J, Koehler GJ, Voss D, Hegemann JH. A second set 
of loxP marker cassettes for Cre-mediated multiple gene knockouts in 
budding yeast. Nucleic Acids Res. 2002;30:e23.
 32. Shao Z, Zhao H, Zhao H. DNA assembler, an in vivo genetic method 
for rapid construction of biochemical pathways. Nucleic Acids Res. 
2009;37:e16.
 33. Maeng JH, Sakai Y, Tani Y, Kato N. Isolation and characterization of a novel 
oxygenase that catalyzes the first step of n-alkane oxidation in Acineto-
bacter sp. strain M-1. J Bacteriol. 1996;178:3695–700.
 34. Wilcox LJ, Balderes DA, Wharton B, Tinkelenberg AH, Rao G, Sturley SL. 
Transcriptional profiling identifies two members of the ATP-binding 
cassette transporter superfamily required for sterol uptake in yeast. J Biol 
Chem. 2002;277:32466–72.
